Captor Therapeutics ® Investor Relations

      Investor Relations

      Appointment of a member of the Company's Supervisory Board

      Publication date: 2022-01-05
      Number: RB ESPI 2/2022

      Current Report No. 2/2022

      Date of preparation: 5 January 2022

      Subject: Appointment of a member of the Company's Supervisory Board

      Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

      The Management Board of Captor Therapeutics S.A. based in Wrocław ("Company") informs that on 5 January 2022, the Company's Supervisory Board appointed Mr. Robert Florczykowski to the Company's Supervisory Board, by way of co-option under § 25 of the Company's Articles of Association.

      Mr. Robert Florczykowski is not listed in the Register of Insolvent Debtors maintained under the Act on the National Court Register. Mr. Robert Florczykowski does not run any competitive activities to the business of the Company and is not a partner in any competitive civil law partnerships or partnerships, nor is he a member of the governing bodies of any company nor the governing bodies of any other competitive legal entity.

      Mr. Robert Florczykowski is co-founder and portfolio manager of the investment fund Third Dot within Opoka TFI S.A. Previously he managed global funds investing in technology and healthcare sector within the PKO TFI S.A. Mr. Robert Florczykowski graduated from the faculty of "Quantitative Methods in Economics" at the Warsaw School of Economics and "Mathematics" at the University of Warsaw. He also completed postgraduate studies in "Molecular Biology" at Jagiellonian University and "Postgraduate Studies in Accounting and Finance" at Warsaw University of Technology Business School, organized in cooperation with ACCA Institute. Other information about the education, qualifications, and professional career of Mr. Robert Florczykowski is presented in the attachment to this report.                      


      Attachments: